Survey shows pharma’s doubts over Brexit outcome
The pharmaceutical industry is one of the most dynamic in the UK and is a...
Read More...
Focus:
-
![]()
Human-level intelligent machines will arrive in a decade: Technology industry veteran
Human-level intelligent machines are just a decade away, according to a leading technology expert and...
Read More...
-
![]()
Achillion’s C3G trial earmarked for success, despite slow recruitment
Achillion Pharmaceuticals is developing a therapy specifically for C3G, though it is expected to face...
Read More...
-
![]()
Could cutting out mediators let cancer research off the leash?
University of Texas MD Anderson Cancer Center has been talking about its innovative approach to...
Read More...
-
![]()
UK drug stockpiling begins as CMOs complain of Brexit uncertainty
Sanofi, Novartis, AstraZeneca and Roche are among the companies planning to stockpile drugs in preparation...
Read More...
-
![]()
Top companies in the IBD space
Currently there are five major companies that have approved branded drugs in the inflammatory bowel...
Read More...
-
![]()
Akcea’s cardiovascular drug should meet Phase III benchmarks before CVOT
Akcea Therapeutics should first plan for a Phase III clinical study for AKCEA-APO(a)-LRx to determine...
Read More...
-
![]()
Gossamer to decide lead autoimmune candidate strategy by end of 2018
Gossamer Bio is making plans for an upcoming autoimmune trial in 2019 following its recent...
Read More...
-
![IPS_cells]()
Pioneering stem cell trial for Parkinson’s disease begins in Japan
A pioneering investigator-initiated trial in Japan is set to attract the attention of patients, physicians,...
Read More...
-
![]()
Amazon’s future in US healthcare
Amazon’s significant growth during the last several years has been particularly of interest to the...
Read More...
